期刊文献+

免疫抑制剂FK506在器官移植中应用的新进展 被引量:6

暂未订购
导出
出处 《重庆医学》 CAS CSCD 2002年第12期1259-1261,共3页 Chongqing medicine
  • 相关文献

参考文献22

  • 1Bekersky I,Dressler D,Mekki Q.Effect of time of meal consumption on bioavailability of a single oral 5mg tacrolimus dose [J].J Clin Pharmacol,2001,41(3):289.
  • 2苏泽轩,黄洁夫.现代移植学[M].北京:人民卫生出版社,1999.117.
  • 3Ochiai T,Nagara M,Nakajima K,et al.Prolongation of canine renal allograft sursival by treatment with FK506[J].Transplant Proc,1987,19(s6):53.
  • 4Oike F,Talpe S,Otsuka M,et al.A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine[J].transplantion,2000,69(11):2304.
  • 5Sigalet DL,Williams DC,Garola R,et al. Impact of T FK506 and steroids on adaptation after intestinal resection or segmental transplantation [J].Pediatr Transplant,2000,4(1):12.
  • 6Guo WH,Tian L,Chan KL,et al.Role of CD4+and CD8+T cells in early and late acute rejection of small bowel allograft [J].J Pediatr Surg,2001,36(2):352.
  • 7Yeis A,Reinhard T,Sundmacher R,et al.A comparative investigation of FK506 and cyclosporine A in murine corneal transplantation [J].Graefes Arch Clin Exp Ophthalmol,1998,236(10):785.
  • 8Platz KP,Mueller AR,Spree E,et al.Liver transplantation for alcoholic cirrhosis [J].Transpl Int,2000,13(Supl 1):s127.
  • 9Pirenne J,Aerts R,Yoong K,et al.Liver transplantation for polycystic liver disease [J].Liver Transpl,2001,7(3):238.
  • 10叶启发,沙波,宫念樵,田超睿,夏穗生.他克莫司在20例肝移植中的应用[J].中华器官移植杂志,2000,21(4):240-241. 被引量:7

二级参考文献8

  • 1SawadaS,SuzukG,KawaseY,etal.Novelimmunosuppressivea gent,FK5 0 6invitroeffectsontheclonedTcellactivation[].JIm munol.1987
  • 2DharDK,NagasueN,KimotoT,etal.Thesalutaryeffectof 5 0 6inischemiareperfusioninjuryofthecanineliver[].Transplantation.1992
  • 3DavidO,TaylorMD,RDouglasEnsley,etal.Mycophenolatemofetil(RS -61 4 4 3) :preclinical,clinical,andthree-yearexperienceinhearttransplan tation[].JHeartLungTransplant.1994
  • 4Asante Korang A,Boyle GJ,Webber SA.Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects[].The Journal of Heart and Lung Transplantation.1996
  • 5Mathieu P,Carrier M,White M.Conversion of cyclosporine A to tacrolimus following heart transplantation[].Canadian Journal of Cardiology.1999
  • 6Kobashigawa J,Miller,L,Renlund D,et al.A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients.Mycophenolate Mofetil Investigators[].Transplantation.1998
  • 7Renlund DG,Gopinathan SK,Kfoury AG,et al.Mycophenolate mofetil(MMF) in heart transplantation: rejection prevention and treatment[].Clinical Transplantation.1996
  • 8Dubrey SW,Holt DW,Banner N.Measurement of mycophenolate mofetil plasma levels after heart transplantation and a potential side effect of high levels[].Therapeutic Drug Monitoring.1999

共引文献19

同被引文献97

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部